GGrantIndex
← Leaderboards

Yevgeniy Vinogradskiy

Thomas Jefferson University

$2,110,476
Attributed
$5,096,031
Total exposure
5
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.1M · FY201625
$2M$1.5M$1M$500K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,702,057 · 4
AHRQ$393,974 · 1

By mechanism

R01$2,979,675 · 2
UH3$1,058,781 · 1
UG3$663,601 · 1
R18$393,974 · 1

Top collaborators

Most similar at Thomas Jefferson University

Same institution · by research overlap

Others in their field

Top investigators on “Clinically Significant

Research focus

Clinically SignificantRadiation PneumonitisMalignant Neoplasm Of LungClinical TrialsToxic EffectImproved OutcomeLungRadiationCancer PatientRadiation TherapyMapsChestStandard Of CareClinical CareDoseImaging ModalityImageInnovationProspectiveData SetComputer SoftwareGenerationsSide EffectTreatment Side Effects

Grant awards (22)

Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$420,407
UH3 · FY2025 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$320,465
R01 · FY2025 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$30,947
R01 · FY2025 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$15,043
R01 · FY2025 · CA · contact PI
Systems Engineering for Ransomware Attack Response Resiliency in Radiation Oncology$393,974
R18 · FY2024 · HS · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$348,431
R01 · FY2024 · CA · contact PI
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$223,430
UH3 · FY2024 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$130,633
R01 · FY2024 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$28,114
R01 · FY2024 · CA · contact PI
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$414,944
UH3 · FY2023 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$394,941
R01 · FY2023 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$102,351
R01 · FY2023 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$14,549
R01 · FY2023 · CA · contact PI
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$316,568
UG3 · FY2022 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$118,825
R01 · FY2022 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$383,072
R01 · FY2021 · CA · contact PI
Quantitative Lung Function Imaging to Reduce Toxicity for patients treated with Radiation and Immunotherapy$347,033
UG3 · FY2021 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$75,749
R01 · FY2021 · CA · contact PI
Development of a Novel Lung Function Imaging Modality for comprehensive management of lung cancer$398,856
R01 · FY2020 · CA · contact PI
Clinical trial personalizing radiation therapy through a novel lung function imaging modality$161,657
R01 · FY2018 · CA · contact PI
Clinical trial personalizing radiation therapy through a novel lung function imaging modality$237,451
R01 · FY2017 · CA · contact PI
Clinical trial personalizing radiation therapy through a novel lung function imaging modality$218,591
R01 · FY2016 · CA · contact PI